RegulatoryApr 15, 2026, 04:36 PM
Oncotelic Therapeutics Files 2025 Annual Report on Form 10-K
AI Summary
Oncotelic Therapeutics, Inc. has filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The company confirmed it has filed all reports required by the Securities Exchange Act of 1934 during the preceding 12 months. Oncotelic Therapeutics is designated as a non-accelerated filer and a smaller reporting company.
Key Highlights
- Filed Form 10-K for fiscal year ended December 31, 2025.
- Confirmed compliance with SEC filing requirements.
- Designated as a non-accelerated filer.
- Designated as a smaller reporting company.
Price Impact
More from OTLC